Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
3411411
Title:
DÉRIVÉS DE 1H-INDAZOLE-3-CARBOXAMIDE ET COMPOSÉS SIMILAIRES EN TANT QU'INHIBITEURS DU FACTEUR D POUR LE TRAITEMENT DE MALADIES CHARACTERISÉS PAR UNE ACTIVITÉ ABERRANTE DU SYSTÈME COMPLÉMENTAIRE, COMME P.E. TROUBLES IMMUNOLOGIQUES
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
177480449
WO application number:
US2017015953
Type:
European patent granted for BE
Status:
Open
Publication number:
3411411
WO publication number:
WO2017136395
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
01/02/2017
Grant date:
19/05/2021
EP publication date:
12/12/2018
WO publication date:
10/08/2017
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
19/05/2021
EP B1 publication date:
19/05/2021
EP B2 publication date:
EP B3 publication date:
26/01/2022
Lapsed date:
Expiration date (if granted and all annual fees paid):
01/02/2037
Applicant
Name:
Biocryst Pharmaceuticals, Inc.
Legal Form:
From:
19/05/2021
Address:
4505 Emperor Blvd., Durham, North Carolina 27703, United States (US)
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed
2
Bulletin heading:
EP4
Journal edition number:
2022/02
Publication date:
25/02/2022
Description:
Contains data concerning granted European patents granted and republished in amended form (B2 or B3 publications) for Belgium and for which no translation needed to be filed
European Patent Bulletin
1
Issue number:
202120
Publication date:
19/05/2021
Description:
Grant (B1)
2
Issue number:
202129
Publication date:
21/07/2021
Description:
Request for limitation Filed (Art.105a)
3
Issue number:
202147
Publication date:
24/11/2021
Description:
Request for limitation of patent allowed
4
Issue number:
202204
Publication date:
26/01/2022
Description:
Limited Patent Specification (B3)
5
Issue number:
202147
Publication date:
24/11/2021
Description:
International Patent Classification Changed
6
Issue number:
202147
Publication date:
24/11/2021
Description:
Title of invention Modified
7
Issue number:
202125
Publication date:
23/06/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed